Rocket


Overview
Financials
News + Filings
Key Docs
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



WESTMOUNTAIN Co (WASM) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/15/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
02/07/2019 8-K Quarterly results
01/03/2019 8-K Quarterly results
11/20/2018 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Stock Purchase Agreement",
"Form of Promissory Note",
"Common Stock Purchase Warrant"
11/09/2018 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/23/2018 8-K Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Changes in Registrant's Certi...
Docs: "Agreement of Merger and Plan of Reorganization by and among the Registrant, WASM Acquisition Corp. and CytoBioscience, Inc",
"Lock-up Agreement between the Registrant and the officers, directors and shareholders party thereto",
"Securities Purchase Agreement between the Registrant and the investor parties thereto",
"Investment Banking Agreement between Registrant and Divine Capital",
"Letter from EKS&H LLLP to the Securities and Exchange Commission",
"San Antonio, TX – – March 23, 2018 – CytoBioscience, Inc. , a revenue-generating ion channel screening business providing medical instrumentation and research services to organizations in the pharmaceutical and drug research market, today announced that it has closed a merger with WestMountain Company , effective March 19, 2018. On March 19, 2018, WestMountain entered into a Merger Agreement with CytoBioscience, Inc., a Delaware corporation . As per the terms of the Merger Agreement, a subsidiary of WestMountain merged into CytoBioscience, with CytoBioscience surviving the merger and becoming a wholly-owned subsidiary of WestMountain, and the shareholders of CytoBioscience becoming shareholders of WestMountain. Pursuant to terms of the Merger Agreement, all outstanding shares of capital st..."
12/28/2017 8-K Other Events
12/21/2017 8-K Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets
11/30/2017 8-K Other Events
10/19/2016 8-K Quarterly results
09/28/2016 8-K Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
Docs: "Letter from MaloneBailey, LLP to the Securities and Exchange Commission"
11/17/2011 8-K Form 8-K - Current report
10/28/2011 8-K Form 8-K - Current report
05/05/2011 8-K Form 8-K - Current report
03/22/2010 8-K Form 8-K - Current report

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy